Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc

<< Previous

Bullboard Posts

Next >>

Post by Red~Oneon Nov 04, 2021 12:09pm

427 Views

Post# 34087197

Off Topic eh

1.Don't fall in love with any stock ...
2. Don't risk too much on one event or company... this is usually the result of investors not paying attention to Rule #1
3. Stay focused, especially when the markets are moving. ...take what the markets give you, traders often get in trouble by trying to force a trade, by relying on their bias of a stocks fundamentals
4. Prices move before fundamentals. ...somehow the markets always know beforehand when good news is coming on a stock, evidenced by the price movement and increased volume before the news is released. Quote from Al C.

Copied from another site

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages